Filter

Date Title Topic
30 Sep 2014 ESMO 2014 Press Release: Cancer Medicine Becoming Ever More Precise, Practice-Changing Results at ESMO 2014 Show
29 Sep 2014 ESMO 2014 Press Release: PIK3CA Mutations Blunt Benefit of Anti-HER2 Drugs Breast cancer - Translational research - Anticancer agents & Biologic therapy
29 Sep 2014 ESMO 2014 Press Release: RAS Testing Only the First Step for Choosing Treatment for Metastatic Colorectal Cancer, Important New Data Show Gastrointestinal cancers
29 Sep 2014 ESMO 2014 Press Commentary: Anti-PD-L1 Antibody Shows Promising Activity in Advanced Bladder Cancer after Decades of Silence Genitourinary cancers - Immuno-oncology
29 Sep 2014 ESMO 2014 Press Release: Promising Results Shown with Targeted Approaches in Subsets of Non-Small-Cell Lung Cancer Lung and other thoracic tumours
29 Sep 2014 ESMO 2014 Press Release: New Data on Combination Treatments for Melanoma Melanoma
29 Sep 2014 ESMO 2014 Press Release: Nivolumab Shows Signs of Superior Response Rate Compared to Standard Chemotherapy in Advanced Melanoma Melanoma - Immuno-oncology
29 Sep 2014 ESMO 2014 Press Release: Studies Report New Findings on Treatment Options for Mesothelioma Lung and other thoracic tumours - Immuno-oncology - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: Treatments for Advanced Cancer Less Available in Eastern Europe, Reveals ESMO Survey Bioethics, legal and economic issues
28 Sep 2014 ESMO 2014 Press Commentary: CLEOPATRA Trial Changes Standard Therapy for Metastatic HER2 Positive Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: MAGRIT Phase III Trial Results Raise Questions About the Future of Lung Cancer Vaccination Lung and other thoracic tumours - Immuno-oncology
28 Sep 2014 ESMO 2014 Press Release: Many Patients Lack Information About the Use of Targeted Therapies, Oncologists Say Bioethics, legal and economic issues
28 Sep 2014 ESMO 2014 Press Release: Significant Presence of Women in Oncology, but Still Under-Representation in Leadership Positions, Greek Survey Shows Bioethics, legal and economic issues
28 Sep 2014 ESMO 2014 Press Release: Adding Cediranib to Chemotherapy Improves Progression-Free Survival for Metastatic or Recurrent Cervical Cancer, Phase II Trial Shows Gynaecologic malignancies - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: Pertuzumab Adds 16 Months Survival Benefit to Trastuzumab and Chemotherapy Treatment for HER2-Positive Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy